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Type-2 diabetes (T2D) is a complex disease characterized by insulin resistance in target
tissues and impaired insulin release from pancreatic beta cells. As central tissue of glucose
homeostasis, the pancreatic islet continues to be an important focus of research to
understand the pathophysiology of the disease.The increased access to human pancreatic
islets has resulted in improved knowledge of islet function, and together with advances
in RNA sequencing and related technologies, revealed the transcriptional and epigenetic
landscape of human islet cells. The discovery of thousands of long non-coding RNA
(lncRNA) transcripts highly enriched in the pancreatic islet and/or speciﬁcally expressed
in the beta-cells, points to yet another layer of gene regulation of many hitherto unknown
mechanistic principles governing islet cell functions. Here we review fundamental islet
physiology and propose functional implications of the lncRNAs in islet development and
endocrine cell functions.We also take into account important differences between rodent
and human islets in terms of morphology and function, and suggest how species-speciﬁc
lncRNAs may partly inﬂuence gene regulation to deﬁne the unique phenotypic identity of
an organism and the functions of its constituent cells. The implication of primate-speciﬁc
lncRNAs will be far-reaching in all aspects of diabetes research, but most importantly in the
identiﬁcation and development of novel targets to improve pancreatic islet cell functions
as a therapeutic approach to treat T2D.
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INTRODUCTION
The ﬁeld of pancreatic islet research has largely beneﬁted from the
use of animal models, particularly in the investigation of molec-
ular processes governing islet development and functions using
rodents. While many features of rodent islets have been observed
to reﬂect those found in humans, the increasing availability of
human pancreatic islets for basic cell physiological and histolog-
ical research has made it evident that important differences exist
in terms of islet architecture (Brissova et al., 2005; Cabrera et al.,
2006; Fujita et al., 2011; Wang et al., 2013), and islet cell func-
tions (Ashcroft and Rorsman, 2012; Rorsman and Braun, 2013;
Gylfe and Gilon, 2014). Moreover advances in RNA sequenc-
ing (RNA-seq) and complementary “transcriptome annotation”
technologies enabled the exploration of the transcriptional and
epigenetic landscape of human islet cells in unprecedented resolu-
tion revealing both short and long non-coding RNAs (lncRNAs)
important for islet function (Eliasson and Esguerra, 2014). Here
we will focus on lncRNA transcripts in pancreatic islets. The pres-
ence of lncRNAs highly enriched in the pancreatic islet and/or
speciﬁcally expressed in the beta-cells provides a rich source of
novel modes of gene regulation governing islet functions. More-
over, recent studies suggest the presence of a large proportion of
primate-speciﬁc lncRNAs (Derrien et al., 2012). While evolution-
ary conservation of gene loci across broad phyla strongly points
to a functional role of corresponding gene products, and hence
more likely contribute to the phenotype, we would like to argue
that species-speciﬁc transcripts play a signiﬁcant role in deﬁning
the unique phenotypic identity. Currently however, experimen-
tal data that links primate-speciﬁc lncRNAs to the human islet
phenotype are limited. It will be a daunting task to evaluate
the connection between primate-speciﬁc lncRNAs and human
islet speciﬁc protein expression. In this review we try to answer
the questions: (1) what are the potential roles of lncRNAs in
islet development and endocrine cell function and, (2) can we
attribute many of the observed islet morphological and functional
differences in different species on non-evolutionary-conserved
lncRNAs?
PANCREATIC ISLETS OF LANGERHANS AND TYPE-2
DIABETES
The islets of Langerhans in the pancreas are central to carbohy-
drate homeostasis inhighermetazoans. In vertebrates, the islets are
composed primarily of alpha and beta cells which secrete glucagon
and insulin, respectively. Glucagon triggers glycogenolysis in the
liver where glycogen reserves are converted into glucose prior to
release into the blood stream. Glucagon also mediates control
of glucose production by triggering the phosphorylation of key
enzymes that either inhibit glucose-requiring glycolysis or stim-
ulate gluconeogenesis (Gromada et al., 2007). Hence, glucagon is
secreted during periods of hypoglycemia when blood glucose lev-
els are low, such as during starvation, fasting or exercise. Patients
with T2D have increased glucagon secretion that exaggerates the
disease state, and it is suggested that dysfunctional glucagon
is due to impaired intrinsic glucose regulation (Rorsman et al.,
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2008) and/or loss of the characteristic phasic relationship between
insulin and glucagon secretion (Gylfe and Gilon, 2014).
The effect of the insulin hormone is counter-regulatory to
glucagon. Hyperglycemic conditions stimulate the beta cells to
release insulin into the blood stream. This promotes glucose
uptake into target tissues, e.g., fat and muscle, resulting in
decreased blood glucose levels. Insulin resistance therefore refers
to a pathophysiological condition when tissues fail to respond
to normal insulin levels, thereby triggering an adaptive com-
pensatory response from the beta cells to release more insulin
(Prentki and Nolan, 2006). While such compensatory beta cell
adaptations may provide short-term relief, the long term conse-
quence to the beta cells is deleterious: beginning with impaired
insulin secretion capacity to outright beta cell failure as diabetes
progresses.
Evidence so far point to combined effects of reduced beta-
cell mass and impaired beta-cell function as primary drivers of
T2D development (Meier and Bonadonna, 2013). Previous stud-
ies using immunohistochemical methods showed reduced beta
cell mass in human T2D islets due to apoptosis (Butler et al.,
2003), although lineage tracing of FoxO1-deﬁcient beta cells in
mice suggests that such beta cell mass reduction could also be
due to dedifferentiation of the beta cells into alpha cells (Talchai
et al., 2012). Our recent ultrastructural analyses of electromicro-
scopic images from human islet preparations however, indicate
that beta cell mass is not signiﬁcantly reduced in human T2D
islets, implying that the pathogenesis lies primarily in impaired
beta cell function, e.g., defective insulin production and/or secre-
tion (Dayeh et al., 2014), which could be partly attributed to
reduced expression of key beta cell-speciﬁc transcriptional reg-
ulators including MAFA, NKX6.1, and PDX1 (Guo et al., 2013).
Indeed, many of the genes in the vicinity of single nucleotide
polymorphisms (SNPs), which could be linked to predisposition
to T2D, are usually involved in pancreatic beta cell functions
(Groop and Lyssenko, 2009; Rosengren et al., 2012). Moreover,
epigenetic changes in islets from T2D patients correlated with
expression of genes involved in insulin secretion (Dayeh et al.,
2014).
COMPARATIVE ANATOMY OF HUMAN AND RODENT ISLETS
A striking feature of isolated islets, regardless of species they are
derived from, is their coherence into a compact cluster of cells.
The earliest investigations were therefore focused in elucidating
the types of endocrine cells constituting the islet, and whether
the different islet cell types exhibit spatial organization. Here we
concentrate on the main cytoarchitectural features of rodents (rat
and mice) and human islets. A comprehensive treatise on islet
comparative anatomy among different taxonomic groups from
ancient ﬁsh to primates may be found elsewhere (Heller, 2010).
Compared with rodent islets, there is considerable heterogene-
ity in human islets in two levels: (i) islet cellular composition,
proportion and organization, and (ii) distinction between small
and large human islets, including differences in islet composition
depending on their regional location in the pancreas (Brissova
et al., 2005; Cabrera et al., 2006; Fujita et al., 2011; Wang et al.,
2013). Mouse islets comprise up to 75% beta cells mainly in
the core and surrounded by a mantel of ∼20% alpha cells,
and ∼5% delta (somatostatin) cells (Brissova et al., 2005). In
contrast, human islets have more scattered, random-like arrange-
ment of the different islet cell types, with many beta cells also
prominently located on the outer periphery (Figure 1A). On aver-
age, human islets contain ∼55% beta cells, ∼35% alpha cells,
and ∼10% delta cells (Brissova et al., 2005). There are also other
hormone-producing cells in the islets such as the PP (polypep-
tide) and ghrelin-producing epsilon cells identiﬁed in humans,
rodents, and several mammals. Interestingly, only the adult
human islets harbor a substantial number of ghrelin-producing
epsilon cells (Wierup et al., 2014). During embryonic devel-
opment in certain mammalian species, transient expression of
serotonin-producing enterochromafﬁn cells (Alumets et al., 1983)
and gastrin-producing G-cells have also been demonstrated in
the pancreas (Suissa et al., 2013). Thus there are at least seven
hormone-secreting endocrine cell types identiﬁed in the islets
of different species at some point of pancreatic development
(Wierup et al., 2014). It is worth mentioning that of all the stud-
ied model animals, only the non-human primates are found to
have very similar islet cell distribution and organization as in
humans (Brissova et al., 2005). This could be reﬂected by the
high genetic similarities within the primate clade as shown in a
comprehensive review on comparative genomics of human and
more than a dozen non-human primates (Rogers and Gibbs,
2014).
The parasympathetic and sympathetic innervation patterns
have also been shown to be very different in the human islets,
with considerable implication in the autonomic control of hor-
mone secretion. The human endocrine cells, as opposed to mouse
endocrine cells, have fewer contacts with autonomic axons, which
means less direct autonomic control of endocrine cell functions
(Rodriguez-Diaz et al., 2011a). Instead smooth muscle cells of
human islet blood vessels are found to be innervated with sym-
pathetic ﬁbers, with the implication that hormone secretion may
be modulated by local blood ﬂow (Rodriguez-Diaz et al., 2011a).
Moreover the sparse cholinergic innervation within human islets
appears to be compensated by the ability of the human alpha cells
to secrete acetylcholine,whichprovides paracrine signal to the beta
cells in response to impending increase in glucose concentration
(Rodriguez-Diaz et al., 2011b).
While the many similarities between human and rodent islets
have allowed the dissection of important shared biological pro-
cesses in islet development and function, emerging ﬁndings on
species-speciﬁc differences on pancreatic islet organization and
composition, speciﬁcally between primates and other mammalian
clades, highlight fundamental differences by which glucose home-
ostasis may be controlled. Indeed, the clinical and pathological
features in non-human primate models of T2D impeccably reﬂect
those of human T2D, making the translation of novel therapeu-
tic agents from non-human primates to humans highly predictive
(Hansen, 2012; Harwood et al., 2012). Corollary to such evidence,
utmost caution must be exercised when extrapolating ﬁndings in
rodent models to man when it comes to control of islet devel-
opment, assessment of islet quality, insulin secretion capacity,
and other techniques which may be confounded by the three-
dimensional arrangement of the different endocrine cell types in
the islets (Brissova et al., 2005).
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FIGURE 1 | Potential roles of lncRNA in pancreatic islet development and
endocrine cell function. Majority of lncRNAs are localized in the nucleus and
participate in transcriptional and epigenetic regulation, acting as scaffolds of
transcription and chromatin-modifying factors, or as transcriptional enhancers.
(A) Regardless of species, different lncRNAs may inﬂuence the cell-fate and
maturation of the various endocrine cell types. However, the cytoarchitectural
differences, i.e., islet cellular composition, proportion, organization,
innervations and vascularization patterns, between mouse and human islets
may be partly determined by species-speciﬁc lncRNAs such as the large
cluster of primate-speciﬁc (ps)-lncRNAs discovered in human cells. (B)The
role of lncRNAs in endocrine islet cell functions, here represented by the
components of canonical stimulus-secretion coupling in mouse (left) and
human (right) beta cells, may also be in the level of transcriptional and
epigenetic regulation of factors involved in cell-type speciﬁc functions.
Considerable differences in nutrient sensing, metabolism, exocytotic events
and electrophysiological properties between human and mouse beta cells
may be a consequence of differential regulation of relevant genes, e.g.,
ion-channels and exocytotic proteins, by ps-lncRNAs.
FUNCTIONAL DIFFERENCES BETWEEN HUMAN AND RODENT ISLETS
An obvious consequence of cytoarchitectural/morphological dif-
ferences between human and rodent islets is differences in the
relative accessibility of the different endocrine cell types from
nutrient and paracrine signals. The unique innervation and
vascularization patterns, combined with the apparent random
organization of the various endocrine cells in the human islets
allow formore contact of the cellswith the environment, and closer
interactions between the different islet cell types resulting in more
enhanced paracrine signaling (Cabrera et al., 2006). The effect of
endogenous hormones secreted by the different islet cell types on
one another is not trivial; ghrelin predominately inhibits insulin
secretion (Wierup et al., 2014), somatostatin inhibits both insulin
and glucagon release (Strowski et al., 2000), and both glucagon
and insulin inﬂuence each other’s secretion (Gromada et al., 2007;
Bansal and Wang, 2008). Indeed, the signiﬁcance of the inter-
play between functional alpha- and beta cell regulation in the
pathogenesis of diabetes was highlighted in a recent review (Unger
and Cherrington, 2012), suggesting a major role for dysfunctional
glucagon release in the disease development.
Studies of whole islet physiology reveal subtle but impor-
tant differences between murine and human islets. Even between
mouse and rat islets, difference in insulin secretion in response
to certain metabolites has been demonstrated. For instance, the
absence of malic enzyme in mouse beta cells renders the cells
unresponsive to dimethylsuccinate, in contrast to rat beta cells
(MacDonald, 2002). While nutrient-induced insulin secretion was
found to be globally similar between rodent and human islets,
with the presence of both triggering and amplifying pathways,
the concentration-response curve is shifted to the left in humans,
compatible with the observation that humans have generally lower
plasma glucose levels than rodents (Henquin et al., 2006).
The exact molecular mechanisms underlying discrepancies in
different species regarding the response of islet cells on nutrient
stimulation are not entirely known. However, differences in the
major components of the stimulus-secretion coupling (Figure 1B)
may provide important clues. In human beta cells, the main glu-
cose transporters GLUT-1 and GLUT-3 have considerably higher
afﬁnity for the substrate as exempliﬁed by their lower Km values, 6
and 1 mM, respectively than the main glucose transporter, Glut2,
in rodents with Km of 11 mM (McCulloch et al., 2011; Rorsman
and Braun, 2013). Another aspect of stimulus-secretion coupling
is the electrically excitable nature of beta cells which highlights
the importance of ion channels in generating action potentials
leading to insulin secretion. The KATP channel controls the elec-
trical activity in both mouse and human beta cells, but the resting
membrane conductance at 1 mM glucose is ten times lower in
human beta cell, contributing to initiation of insulin secretion
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at low glucose levels (5–6 mM; Rorsman and Braun, 2013). In
addition, human beta cells are equipped with T-type Ca2+ chan-
nels that are absent in mice. Together with current ﬂow through
voltage- dependent Na+ channel these channels contribute to the
upstroke of the action potential in human beta-cells. (Barnett
et al., 1995; Braun et al., 2008). The ﬁnal increase in Ca2+ trig-
gering exocytosis of insulin granules arise from inﬂux through
L-type and P/Q-type Ca2+ channels in rodent and human beta
cells, respectively (Barg et al., 2001; Braun et al., 2009). The rev-
elation of several electrophysiological differences between rodent
and human beta cells (Rorsman and Braun, 2013), primarily due
to differential expression, and/or transcriptional regulation by yet
unknown principles [alternative splicing, microRNA (miRNA),
lncRNAs], of functional ion channels underscores the impor-
tance of species-speciﬁc genetic basis of regulation of insulin
secretion. More in depth characterization of human islets will
further reveal such species differences in other aspects of molec-
ular control of endocrine hormone secretion. Recently, analyses
of anaplerotic products show much lower dependence of human
islets to the activity of the key anaplerotic enzyme, pyruvate
carboxylase (MacDonald et al., 2011). Finally, in the search for
exocytotic genes differentially expressed in human T2D islets,
synaptotagmin isoforms previously deemed unimportant in mice
beta cell exocytosis, correlated with insulin secretion in humans
(Andersson et al., 2012).
To understand the origin of morphological and functional
differences in rodent and human pancreatic islets, one has to
consider the developmental aspect of endocrine cell differentia-
tion (Figure 1A). Conventional wisdom dictates that regardless
of species, the path from endoderm progenitors to differentiated
hormone-secreting cells of the pancreatic islets is a highly orches-
trated process mediated by precise spatio-temporal interplay of
various transcription factors. However, signiﬁcant differences exist
in the transcriptional repertoire of endocrine cell differentiation
between human and mouse. A survey of known regulators of
mouse endocrine pancreatic cell fate in puriﬁed human beta and
alpha cells reveals that MAFB which is not expressed in adult
mouse beta cells, is present in comparable levels in both human
alpha and beta cells (Dorrell et al., 2011). In the same study, IRX2
previously shown to be expressed only in the developing mouse
pancreas (Petri et al., 2006), was found to persist in adult human
alpha cells. Recently, the pancreas-enriched miR-7 was also found
to negatively regulate Pax6 which has a central role in endocrine
cell differentiation and maintenance of identity (Kredo-Russo
et al., 2012). Although miR-7 is a broadly conserved miRNA, it is
possible that itmay also target other non-conservedmRNAswhich
may impart species-speciﬁc ﬁne-tuning of regulatory circuits in
the context of islet development. Indeed, both evolutionary con-
served and non-conserved targets for individual miRNAs have
been predicted and demonstrated (Betel et al., 2010). The involve-
ment of non-coding RNAs in pancreatic islet development adds
another level of regulation of cell fate trajectories and distinct
cell-type speciﬁc functions.
LONG NON-CODING RNAs
Long non-coding RNAs are transcripts without protein-coding
potential, arbitrarily deﬁned in size by a cut-off length of >200
nucleotides (HUGO Gene Nomenclature Committee; Seal et al.,
2011). Most lncRNAs are transcribed by RNA polymerase II,
and share many properties of mRNAs such as splicing, capping
and polyadenylation (Derrien et al., 2012). Similar to protein-
coding genes, the expression of lncRNAs is tightly regulated and
display spatio-temporal expression patterns, i.e., cell-type spe-
ciﬁc and/or developmental stage-speciﬁc expression (Dinger et al.,
2008; Mercer et al., 2008; Cabili et al., 2011).
Integrative analysis of RNA-seq datawith other complementary
high-throughput “transcript annotation” technologies, e.g., tran-
scription initiation mapping by cap-analysis of gene expression
(CAGE; Kodzius et al., 2006) and identiﬁcation of sites of 5′ and
3′ transcript termini (Ng et al., 2005), reveals that lncRNAs may
generally be categorized with respect to their genomic position
either as “intergenic” (between protein-coding genes), or “genic”
(Derrien et al., 2012). Intergenic lncRNAs or “lincRNAs” (long
intergenic non-coding RNAs) are encoded as distinct transcrip-
tional units within genomic regions which used to be called “gene
deserts.”The“genic” lncRNAs may be exonic, intronic, or overlap-
ping, and can be further classiﬁed as either in the sense or antisense
strand relative to the protein-coding gene (Derrien et al., 2012). An
in-depth investigation on expression dynamics of lncRNAs during
differentiation of human neuroblastoma cells suggests 19 different
genomic architecture classes of lncRNAs based on both their rela-
tive positions with protein-coding genes, and on the orientations
of their transcription (Batagov et al., 2013).
The GENCODE (encyclopædia of genes and gene variants)
project lists 13870 lncRNA genes in the human genome (Ver-
sion 19, July 2013 freeze, GRCh37 – Ensembl 74) and 4074
lncRNA genes in the mouse genome (Version M2, July 2013 freeze,
GRCm38 – Ensembl 74; http://www.gencodegenes.org/; Dunham
et al., 2012). There are other independent efforts in annotating
lncRNAs in the human genome, albeit with surprisingly low over-
lap with the GENCODE annotations. For example, only 39% of
the 4662human lincRNA loci cataloged inCabili et al. (2011) study
intersected with those of GENCODE’s human lncRNAs (Derrien
et al., 2012). Thus, while there is an indisputable consensus about
thewidespread transcription of lncRNAgenes in human and other
mammalian cells, the ﬁeld is still mostly in the exploratory stage,
and both high-throughput biochemical data generation and in sil-
ico analyses warrant further development to aid in standardization
of analytical procedures.
ROLES OF lncRNA
A wide variety of functions have been attributed to lncRNAs
including roles in transcriptional regulation (Penny et al., 1996;
Orom et al., 2010; Santoro et al., 2013), as architectural deter-
minants of subcellular structures (Clemson et al., 2009; Batista
and Chang, 2013), in epigenetic inheritance/chromatin dynamics
(Khalil et al., 2009; Tsai et al., 2010), and most recently in higher-
order chromosomal organization (Hacisuleyman et al., 2014).
Here we will only brieﬂy mention the general characteristics of
lncRNA mechanisms of action. A more detailed description of
some well-characterized lncRNAs is described elsewhere in recent
reviews (Kornfeld and Bruning, 2014; Yang et al., 2014a).
As entities of transcriptional control, it is emerging that
lncRNAs may perform their functions in at least two ways:
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(i) as scaffoldings in ribonucleoprotein complexes, e.g., tran-
scription or chromatin-modifying factors, acting in cis or in
trans on the genome (Yang et al., 2014a), and (ii) as inci-
dental by-products of a negative type of transcriptional regu-
lation termed, “transcriptional interference” (Kornienko et al.,
2013). Prior knowledge about the mechanism of action of a
few well-characterized lncRNAs such as the HOTAIR (Rinn
et al., 2007), and the observation that as many as 24% of
human lincRNAs bind the polycomb repressive complex 2
(PRC2), responsible for transcriptional repression of speciﬁc
genes by methylation of H3K27 (Khalil et al., 2009) strengthened
the hypothesis that lncRNAs provide the speciﬁcity in guid-
ing chromatin-modifying complexes into exact regions in the
genome. Whether the guiding mechanism is based on sequence-
complementarity between the lncRNA and genomic DNA, or
other motif-recognition process remain to be seen (Guttman
and Rinn, 2012). In a separate attempt to functionally cate-
gorize lncRNAs en masse, it was shown that many lncRNAs
have enhancer-like properties, activating and/or potentiating the
expression of neighboring protein-coding genes (Orom et al.,
2010).
Recently, it was shown that a lncRNA called “functional
intergenic repeating RNA element” (Firre), facilitates trans-
chromosomal interactions, in which genes involved in energy
metabolism and adipogenesis are brought in close proximity, pre-
sumably to allow efﬁcient co-regulation of genes in the same
biological pathway (Hacisuleyman et al., 2014).
In summary, lncRNAs characterized thus far display dis-
tinct functions and mode of regulation, again reminiscent of
protein-coding genes belonging to broad functional ontologies.
Nevertheless, as exempliﬁed by PRC2-binding lncRNAs, or the
enhancer-like lncRNAs, consensus mechanisms of action are
emerging for many lncRNAs which may permit their classiﬁcation
into speciﬁc functional categories.
EVOLUTIONARY CONSERVATION OF lncRNAs
Previous experience from large-scale, computational prediction
of protein-coding genes as crucial ﬁrst step in de novo genome
annotation, showed thatDNA sequence conservation across broad
phyla is a good indicator of genuine coding potential, i.e., that
the gene will produce an mRNA transcript and will eventually
be translated, and hence has biologically meaningful functions.
Although lncRNAs have been experimentally discovered from
transcription data, it is still deemed necessary to use the crite-
rion of evolutionary conservation to help distinguish functional
RNA transcripts from transcriptional and experimental noise.
However, sequence conservation alone is inherently problem-
atic for non-coding RNA genes whose functional gene products
act in the level of secondary or tertiary structural RNA features.
Formation of secondary RNA structures are not evolutionary con-
strained to maintain nucleotide sequences in the same way that
protein-coding genes are constrained to maintain speciﬁc codon
sequences to ensure functional proteins. For instance,RNAhairpin
loops which are ubiquitous secondary structural feature of vir-
tually all functional non-coding RNA molecules may be formed
irrespective of the nucleotide sequence, as long as energetically
favorable base-pairings in the hairpin stem are maintained. It
is perhaps not surprising that when standard sequence align-
ment procedures are used to assess the conservation of lncRNAs
in various species, consistently modest sequence similarity is
found. Indeed, compared to protein-coding sequences aligned
between different species, much lower sequence identities are
found for each of the 993 syntenically paired orthologous lin-
cRNAs in mammals and other vertebrates (Cabili et al., 2011).
However, the promoter regions of the lncRNAs are shown to
be more conserved than the exonic regions which imply sim-
ilar regulation and potentially analogous roles of orthologous
lncRNAs in different species (Guttman et al., 2009; Derrien et al.,
2012).
Remarkably, despite employing meticulous approaches in
aligning genomes, one study ﬁnds only 12% (993 lincRNAs) of
human lincRNAs with orthologous sequences in another verte-
brate species (Cabili et al., 2011),whileGENCODEv.7 reports 30%
of all annotated lncRNAs, ∼4500 lncRNAs, to be clearly primate-
speciﬁc (Derrien et al., 2012). The manually curated lncRNA
database (www.lncrnadb.org) lists a number of primate-speciﬁc
lncRNAs (Amaral et al., 2011), including the 482-nucleotide long
HULC RNA found to be highly upregulated in human hepato-
cellular carcinoma (Panzitt et al., 2007). One recently investigated
human-speciﬁc non-coding RNA, miR-941, is expressed in the
brain and regulates genes involved in neurotransmitter signal-
ing (Hu et al., 2012). Thus, conservation of gene locus, let alone
gene sequence across broad phyla is not a strict requirement for
biological function. After all, it is the evolution of genetic dif-
ferences that ultimately drives speciation. The non-conserved
lncRNAs must be bona ﬁde elements of genetic programs
which specify phenotypic/morphological differences between
organisms.
EXPRESSION OF lncRNAs IN HUMAN PANCREATIC ISLET
CELLS
By integrating transcriptomics data and chromatin maps, 1128
lncRNAs were reliably identiﬁed in puriﬁed human pancreatic
islets (Moran et al., 2012). Many of the lncRNAs were speciﬁ-
cally expressed in the islets and beta cells, suggesting important
roles in the developmental programming, proper functioning
and/or maintenance of the pancreatic endocrine tissue. Indeed,
the expression levels of a dozen lncRNAs were found to ﬂuc-
tuate during stage-speciﬁc embryonic stem cell differentiation
relative to the ﬁnal expression in in vivo functional endocrine
cells, and at least two lncRNAs, HI-LNC78 and HI-LNC80, exhib-
ited dynamic upregulation when the islets were exposed to high
glucose concentrations (Moran et al., 2012). In a separate deep
RNA-seq study of puriﬁed human beta cells, 148 lincRNAs were
found to be overexpressed in beta cells compared to non-beta
cells (Nica et al., 2013), while another study discovered 12 beta
cell-speciﬁc and 5 alpha cell-speciﬁc lncRNAs (Bramswig et al.,
2013). Taken together, these ﬁndings suggest the importance of
cell-type- and/or condition-speciﬁc expression of lncRNAs in the
human pancreatic islet.
All the aforementioned studies on lncRNAs in the human
pancreatic islets are exploratory in nature, and no particular
mechanism of action has been attributed so far on any of the
identiﬁed lncRNAs in the islet cells. Elucidating the molecular
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functions of islet cell-speciﬁc or – enriched lncRNAs will be chal-
lenging because of the generally low conservation of lncRNAs in
commonly used rodent and in vitro models. Indeed, RNA-seq
of mouse pancreatic beta cell transcriptome corroborates pre-
vious ﬁndings about the very weak conservation of lincRNAs
in humans (Ku et al., 2012), although it was shown that for
a considerable number of lincRNAs, short conserved stretches
of sequences may be enough to guarantee conserved function
in vertebrate embryonic development (Ulitsky et al., 2011). In
view of species-speciﬁc expression of many lncRNAs, the recently
developed human beta cell lines from Ravassard et al. (2011),
EndoC-BH1 and EndoC-BH2 (Scharfmann et al., 2014) will be
valuable in dissecting the molecular functions of lncRNAs in the
beta cell.
POTENTIAL ROLES OF lncRNAs IN THE DEVELOPMENT, FUNCTION AND
MAINTENANCE OF PANCREATIC ISLET CELLS: ACQUISITION OF
SPECIES-SPECIFIC ISLET PHENOTYPE/MORPHOLOGY AND CELL-TYPE
SPECIFIC FUNCTIONS
In light of scarce experimental data on recently discovered lncR-
NAs in islet cells, we can only infer about their potential molecular
roles based on ﬁndings in other cell types. The various mecha-
nisms by which lncRNAs were shown to exert their functions will
undoubtedly also inﬂuence pancreatic islet cells in terms of cel-
lular differentiation and development, speciﬁcally in maintaining
cellular identity and plasticity. They may also be important com-
ponent of islet cells stress response, such as in activating beta cell
compensatory mechanisms in countering environmental stressors
in T2D. The role of lncRNAs in the acquisition of species-speciﬁc
islet phenotype/morphology, and maintenance of cellular pheno-
type of pancreatic islet cells may be operational in two levels: (i)
between islet cell types of different species, and (ii) among the islet
cells of the same species.
Almost a third of human lncRNAs (∼330 lncRNAs) discovered
in the human islets lack orthologous sequences in mice (Moran
et al., 2012). Given the tendency of many lncRNAs to associate
with components of chromatin-modifying complexes with roles
in embryonic stem cell fates (Dinger et al., 2008;Yang et al., 2014b),
the involvement of primate-speciﬁc lncRNA in the developmental
program of pancreatic islets is possible, and may (i) have direct
contribution to the origin of cytoarchitectural differences between
islets in the different species (Figure 1A), and (ii) contribute to the
differential expression of essential proteins in islet cell secretion
(Figure 1B). In the same line of reasoning, a number of islet cell-
type speciﬁc lncRNAs recently reported (12 beta cell-speciﬁc and
5 alpha cell-speciﬁc; Bramswig et al., 2013) could play essential
roles in conferring cell-type speciﬁc functions in the pancreatic
islets.
The islet cells are constantly subjected to ﬂuctuating nutrient
stimuli and are challenged to respond accordingly tomaintain glu-
cose homeostasis. The coordinated transcription of many genes
required to overcome this challenge relies on transcription factors
activating speciﬁc sets of genes. Indeed, rat islets subjected to dif-
ferent glucose concentrations showed distinct clusters of mRNA
proﬁles suggesting highly coordinated response to varying nutri-
ent stimuli (Bensellam et al., 2009). It will be interesting whether
Firre-like lncRNAs involved in trans-chromosomal interactions
(Hacisuleyman et al., 2014) are present in endocrine cells to
facilitate regulation of cell-type speciﬁc pathways by acting as scaf-
folds guiding transcription factors to target genes. Many of the
identiﬁed human islet lncRNAs lie adjacent to islet-speciﬁc chro-
matin domains and protein-coding genes (Moran et al., 2012), a
striking example beingHI-LNC25whose closest neighbor isMAFB
which is a regulator of islet-cell maturation (Artner et al., 2007)
and as was discussed earlier absent in adult mouse beta cells,
but present in both human alpha and beta cells (Dorrell et al.,
2011).
Enhancer elements are also key determinants of islet-speciﬁc
gene activity (Pasquali et al., 2014). Notably, Cabili et al. (2011)
report that 27% (∼1200) of human lincRNAs overlap with known
enhancer regions in the genome. It will be interesting to exam-
ine the presence of lncRNAs in human pancreatic islet enhancer
clusters reported to be enriched in T2D risk-associated variants
(Pasquali et al., 2014).
Extensive mapping of the epigenome of whole human pan-
creatic islets (Bhandare et al., 2010; Gaulton et al., 2010; Stitzel
et al., 2010; Dayeh et al., 2014), and of puriﬁed islet cells
(Bramswig et al., 2013; Dayeh et al., 2014), reveal cell-type spe-
ciﬁc epigenetic landscape delineating sites of active/inactive gene
transcription. The majority of lncRNAs shown to associate with
various chromatin-modifying factors are tantalizing candidate
factorswhich could provide additionalmolecular speciﬁcity in tar-
geting epigeneticmarkers in the pancreatic islet cells. It is tempting
to hypothesize that primate-speciﬁc lncRNAs could be involved in
specifying the expression of certain components of the stimulus-
secretion coupling in the beta cells, which in turn potentially
contributes in species-speciﬁc response of beta cells to nutrient
stimuli (Figure 1B).
CONCLUSION
The pervasive nature of eukaryotic gene transcription revealed
by next-generation sequencing and associated technologies for
mapping transcriptional activity brought into the limelight a
plethora of non-coding RNA classes of hitherto unknown func-
tions. The existence of long functional RNA molecules provides
tantalizing hypotheses on how chromatin-modifying and tran-
scription factors may act upon their genomic targets in a highly
loci-speciﬁc recognition process. This provides an important
mechanistic insight into how speciﬁcity is achieved by various
factors in pancreatic islets cells to coordinate the regulation of
multiple genes responsible for cell-type speciﬁc phenotypes and
functions.
The potential roles of lncRNAs in pancreatic islet development,
speciﬁcally in endocrine cell-fate determination and subsequent
maintenance of cellular identities and functions, will broaden our
understanding of pancreatic islets, and hence open up new possi-
bilities in identifying novel therapeutic targets in treating type-2
diabetes (T2D). However, the implication of numerous primate-
speciﬁc lncRNAs will be a particular challenge in the ﬁeld which
heavily depends on rodent models when trying to elucidate the
molecular basis ofmetabolic pathophysiologies. Inparticular, con-
sidering the complex ethical issues involved, the in vivo roles of
primate-speciﬁc lncRNAs will pose nagging questions in many
years to come.
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